This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Phanuphak P, Locharernkul C, Panmuong W, Wilde H. A report of three cases of AIDS in Thailand. Asian Pac J Allergy Immunol. 1985;3:195-9.PhanuphakPLocharernkulCPanmuongWWildeHA report of three cases of AIDS in ThailandAsian PacJ Allergy Immunol198531959Search in Google Scholar
Ruxrungtham K, Brown T, Phanuphak P. HIV/AIDS in Asia. Lancet. 2004; 364:69-82.10.1016/S0140-6736(04)16593-8RuxrungthamKBrownTPhanuphakPHIV/AID S in AsiaLancet20043646982Open DOISearch in Google Scholar
UNAIDS. HIV in Asia and the Pacific. Bangkok, Thailand: UNAIDS Regional Support Team for Asia and the Pacific, 2013.UNAIDS. HIV in Asia and the PacificBangkok, ThailandUNAIDS Regional Support Team for Asia and the Pacific2013Search in Google Scholar
UNAIDS. Global Report: UNAIDS report on the global AIDS epidemic 2013. Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS (UNAIDS), 2013.UNAIDS. Global Report: UNAIDS report on the global AIDS epidemic2013Geneva, SwitzerlandJoint United Nations Programme onHIV/AIDS (UNAIDS)2013Search in Google Scholar
Vlahov D, Robertson AM, Strathdee SA. Prevention of HIV infection among injection drug users in resource-limited settings. Clin Infect Dis. 2010; 50(Suppl 3):S114-21.10.1086/65148220397939VlahovDRobertsonAMStrathdeeSAPrevention of HIV infection among injection drug users in resource-limited settingsClin Infect Dis201050s11421311455620397939Open DOISearch in Google Scholar
Bai X, Xu J, Yang J, Yang B, Yu M, Gao Y, et al. HIV prevalence and high-risk sexual behaviours among MSM repeat and first-time testers in China: implications for HIV prevention. J Int AIDS Soc. 2014; 17:18848.10.7448/IAS.17.1.1884824993457BaiXXuJYangJYangBYuMGaoYet alHIV prevalence and high-risk sexual behaviours among MSM repeat and first-time testers in China: implications for HIV preventionJ Int AIDS Soc20141718848408225524993457Open DOISearch in Google Scholar
van Griensven F, Thienkrua W, McNicholl J, Wimonsate W, Chaikummao S, Chonwattana W, et al. Evidence of an explosive epidemic of HIV infection in a cohort of men who have sex with men in Thailand. AIDS. 2013; 27:825-32.10.1097/QAD.0b013e32835c546evan GriensvenFThienkruaWMcNichollJWimonsateWChaikummaoSChonwattanaWet alEvidence of an explosive epidemic of HIV infection in a cohort of men who have sex with men in ThailandAIDS2013278253223169330Open DOISearch in Google Scholar
Winter S. Lost in transition: transgender people, rights and HIV vulnerability in the Asia-Pacific Region. Bangkok, Thailand: United Nations Development Programme and the Asia Pacific Transgender Network 2012.WinterSLost in transition: transgender people, rights and HIV vulnerability in the Asia-Pacific RegionBangkok, ThailandUnited Nations Development Programme and the Asia Pacific Transgender Network2012Search in Google Scholar
Suthar AB, Ford N, Bachanas PJ, Wong VJ, Rajan JS, Saltzman AK, et al. Towards universal voluntary HIV testing and counselling: a systematic review and meta-analysis of community-based approaches. PLoS Medicine. 2013; 10:el001496.10.1371/journal.pmed.100149623966838SutharABFordNBachanasPJWongVJRajanJSSaltzmanAKet alTowards universal voluntary HIV testing and counselling: a systematic review and meta-analysis of community-based approachesPLoS Medicine201310e1001496374244723966838Open DOISearch in Google Scholar
Mekthon S. Investment and changing the paradigm from controlling epidemic to ending AIDS. AIDS 2014; 20th International AIDS conference. July 20-25, Melbourne, Australia, 2014. Together with Thailand, we can end AIDS epidemics in Asia. Non-Commercial Satellite. July 21,2014.MekthonSInvestment and changing the paradigm from controlling epidemic to ending AIDSAIDS 2014; 20th International AIDS conference. July 20-25, Melbourne, Australia2014Together with Thailand, we can end AIDS epidemics in AsiaNon-Commercial SatelliteJuly212014Search in Google Scholar
Distribution of all HIV-1 sequences: Asia. From HIV sequence database, 2014. [Cited 2015 February 25], Available from: http://www.hiv.lanl.gov/components/sequence/HIV/geo/geo.compDistribution of all HIV-1 sequences: Asia. From HIV sequence database2014[Cited 2015 February 25], Available fromhttp://www.hiv.lanl.gov/components/sequence/HIV/geo/geo.compSearch in Google Scholar
Feng Y, Wei H, Hsi J, Xing H, He X, Liao L, et al. Identification of a novel HIV type 1 circulating recombinant form (CRF65_cpx) composed of CRF01_ AE and subtypes B and C in Western Yunnan, China. AIDS Res Hum Retroviruses. 2014; 30:598-602.10.1089/aid.2013.0233FengYWeiHHsiJXingHHeXLiaoLet alIdentification of a novel HIV type 1 circulating recombinant form (CRF65_cpx) composed of CRF01_ AE and subtypes B and C in Western Yunnan, ChinaATOS Res Hum Retroviruses201430598602404620324279591Open DOISearch in Google Scholar
Wei H, His J, Feng Y, Xing H, He X, Liao L, et al. Identification of a novel HIV-1 circulating recombinant form (CRF62_BC) in we stern Yunnan of China. AIDS Res Hum Retroviruses. 2014; 30:380-3.10.1089/aid.2013.0235WeiHHisJFengYXingHHeXLiaoLet alIdentification of a novel HIV-1 circulating recombinant form (CRF62_BC) in western Yunnan of ChinaAIDS Res HumRetroviruses2014303803397657224164474Open DOISearch in Google Scholar
Huang SW, Wang SF, Lin YT, Yen CH, Lee CH, Wong WW, et al. Patients infected with CRF07_BC have significantly lower viral loads than patients with HIV-1 subtype B: mechanism and impact on disease progression. PLoS One. 2014; 9 :e 114441.10.1371/journal.pone.0114441HuangSWWangSFLinYTYenCHLeeCHWongWWet alPatients infected with CRF07BC have significantly lower viral loads than patients with HIV-1 subtype B: mechanism and impact on disease progressionPLoS One20149e114441426366225502811Open DOISearch in Google Scholar
Chow WZ, Takebe Y, Syafina NE, Prakasa MS, Chan KG, Al-Darraji HA, et al. A newly emerging HIV-1 recombinant lineage (CRF58_01B) disseminating among people who inject drugs in Malaysia. PLoS One. 2014; 9:e85250.2446551310.1371/journal.pone.0085250ChowWZTakebeYSyafinaNEPrakasaMSChanKGAl-DarrajiHAet alA newly emerging HIV-1 recombinant lineage (CRF5801B) disseminating among people who inject drugs in MalaysiaPLoS One20149e85250389898324465513Search in Google Scholar
Oyomopito RA, Li PC, Sungkanuparph S, Phanuphak P, Tee KK, Sirisanthana T, et al. TREAT Asia studies to evaluate resistance (TASER) and The TREAT Asia HIV observational database. Evaluating immunologie response and clinical deterioration in treatment-naive patients initiating first-line therapies infected with HIV-1 CRF01_AE and subtype B. J Acquir Immune Defic Syndr. 2013; 62:293-300OyomopitoRALiPCSungkanuparphSPhanuphakPTeeKKSirisanthanaTet alTREAT Asia studies to evaluate resistance (TASER) and The TREAT Asia HIV observational databaseEvaluating immunologie response and clinical deterioration in treatment-naive patients initiating first-line therapies infected with HIV-1 CRF01AE and subtype B. J Acquir Immune Defic Syndr20136229330010.1097/QAI.0b013e31827a2e8f396419723138836Search in Google Scholar
Jiamsakul A, Kantor R, Li PC, Sirivichayakul S, Sirisanthana T, Kantipong P, et al., and on behalf of the TREAT Asia Studies to Evaluate Resistance -Monitoring Study (TASER-M). Comparison of predicted susceptibility between genotype and virtual phenotype HIV drug resistance interpretation systems among treatment-naive HI V-infected patients in Asia: TASER-M cohort analysis. BMC Res Notes. 2012; 5: 582JiamsakulAKantorRLiPCSirivichayakulSSirisanthanaTKantipongPet aland on behalf of the TREAT Asia Studies to Evaluate Resistance -Monitoring Study (TASER-M). Comparison of predicted susceptibility between genotype and virtual phenotype HIV drug resistance interpretation systems among treatment-naive HI V-infected patients in Asia: TASER-M cohort analysisBMC Res Notes2012558210.1186/1756-0500-5-582350515323095645Search in Google Scholar
Li Y Han Y, Xie J, Gu L, Li W, Wang H, et al. CACT0810 group. CRF01_AE subtype is associated with X4 tropism and fast HIV progression in Chinese patients infected through sexual transmission. AIDS. 2014;28:521-30.2447274410.1097/QAD.0000000000000125LiYHanYXieJGuLLiWWangHet alCACT0810 group. CRF01_AE subtype is associated with X4 tropism and fast HIV progression in Chinese patients infected through sexual transmissionAIDS2014285213024472744Search in Google Scholar
Phuphuakrat A, Phawattanakul S, Pasomsub E, Kiertiburanakul S, Chantratita W, Sungkanuparph S. Coreceptor tropism determined by genotypic assay in HIV-1 circulating in Thailand, where CRF01_AE predominates. HIV Med 2014; 15:269-75.2421539910.1111/hiv.12108PhuphuakratAPhawattanakulSPasomsubEKiertiburanakulSChantratitaWSungkanuparphSCoreceptor tropism determined by genotypic assay in HIV-1 circulating in Thailand, where CRF01_AE predominatesHIV Med2014152697524215399Search in Google Scholar
Mulinge M, Lemaire M, Servais JY, Rybicki A, Struck D, da Silva ES, et al. HIV-1 tropism determination using a phenotypic Env recombinant viral assay highlights overestimation of CXCR4-usage by genotypic prediction algorithms for CRF01AE and CRF02_AG [corrected]. PLoS One. 2013; 8:e60566.10.1371/journal.pone.0060566MulingeMLemaireMServaisJYRybickiAStruckDda SilvaESet alHIV-1 tropism determination using a phenotypic Env recombinant viral assay highlights overestimation of CXCR4-usage by genotypic prediction algorithms for CRF01AE and CRF02_AG [corrected]PLoS One20138e60566364851923667426Open DOISearch in Google Scholar
Jiamsakul A, Sirivichayakul S, Ditangco R, Wong KH, Praparattanapan J, Phanuphak P, et al. Transmitted drug resistance in recently infected HIV-positive Individuals from four urban locations across Asia (2007-2010) -TASER-S. AIDS Res Ther. 2015,12:3.10.1186/s12981-015-0043-125685169JiamsakulASirivichayakulSDitangcoRWongKHPraparattanapanJPhanuphakPet alTransmitted drug resistance in recently infected HIV-positive Individuals from four urban locations across Asia (2007-2010) -TASER-SAIDS Res Ther2015123432648025685169Open DOISearch in Google Scholar
Phanuphak P, Sirivichayakul S, Jiamsakul A, Sungkanuparph S, Kumarasamy N, Lee MP, et al. Transmitted drug resistance and antiretroviral treatment outcomes in non-subtype B HIV-1-infected patients in South East Asia. J Acquir Immune Defic Syndr. 2014; 66:74-9.10.1097/QAI.000000000000010824413039PhanuphakPSirivichayakulSJiamsakulASungkanuparphSKumarasamyNLeeMPet alTransmitted drug resistance and antiretroviral treatment outcomes in non-subtype B HIV-1-infected patients in South East AsiaJ Acquir Immune Defic Syndr201466749407477124413039Open DOISearch in Google Scholar
Kiertiburanakul S, Chaiwarith R, Sirivichayakul S, Ditangco R, Jiamsakul A, Li P, et al. Comparisons of primary HIV-1 drug resistance between recent and chronic HIV-1 infection within a sub-regional cohort of Asian patients. PLoS One. 2013; 8:e62057.10.1371/journal.pone.006205723826076KiertiburanakulSChaiwarithRSirivichayakulSDitangcoRJiamsakulALiPet alComparisons of primary HIV-1 drug resistance between recent and chronic HIV-1 infection within a sub-regional cohort of Asian patientsPLoS One20138e62057369495223826076Open DOISearch in Google Scholar
Ananworanich J, Sirivichayakul S, Pinyakorn S, Crowell TA, Trichavaroj R, Weerayingyong J, et al. High prevalence of transmitted drug resistance in acute HIV-infected Thai men who have sex with men. J Acquir Immune Defic Syndr. 2015; 68:481-5.10.1097/QAI.000000000000050225559593AnanworanichJSirivichayakulSPinyakornSCrowellTATrichavarojRWeerayingyongJet alHigh prevalence of transmitted drug resistance in acute HIV-infected Thai men who have sex with menJ Acquir Immune Defic Syndr201568481525559593Open DOISearch in Google Scholar
Ananworanich J, Phanuphak N, de Souza M, Paris R., South East Asia Research Collaboration with Hawaii 004 Protocol Team. Incidence and characterization of acute HIV-1 infection in a high-risk Thai population. J Acquir Immune Defic Syndr. 2008; 49:151-5.10.1097/QAI.0b013e318183a96dAnanworanichJPhanuphakNde SouzaMParisRSouth East Asia Research Collaboration with Hawaii 004 Protocol Team. Incidence and characterization of acute HIV-1 infection in a high-risk Thai populationJ Acquir Immune Defic Syndr200849151518769355Open DOISearch in Google Scholar
Ananworanich J, Fletcher JL, Pinyakorn S, van Griensven F, RV254/SEARCH 010 Study Group. Anovel acute HIV infection staging system based on 4th generation immunoassay. Retrovirology. 2013; 10:56.10.1186/1742-4690-10-56AnanworanichJFletcherJLPinyakornSvan GriensvenFRV254/SEARCH 010 Study Group. Anovel acute HIV infection staging system based on 4th generation immunoassayRetrovirology20131056366962323718762Open DOISearch in Google Scholar
Ananworanich J, Schuetz A, Vandergeeten C, Sereti I. RV254/SEARCH 010 Study Group. Impact of multi-targeted antiretroviral treatment on gut T cell depletion and HIV reservoir seeding during acute HIV infection. PLoS One. 2012; 7:e33948.10.1371/journal.pone.0033948AnanworanichJSchuetzAVandergeetenCSeretiIRV254/SEARCH 010 Study Group. Impact of multi-targeted antiretroviral treatment on gut T cell depletion and HIV reservoir seeding during acute HIV infectionPLoS One20127e33948Open DOISearch in Google Scholar
Schuetz A, Deleage C, Sereti I, Rerknimitr R, RV254/ SEARCH 010 and RV304/SEARCH 013 Study Groups. Initiation of ART during early acute HIV infection preserves mucosal Thl7 function and reverses HIV-related immune activation. PLoS Pathog. 2014; 10: el004543.SchuetzADeleageCSeretiIRerknimitrRRV254/ SEARCH 010 and RV304/SEARCH 013 Study Groups. Initiation of ART during early acute HIV infection preserves mucosal Thl7 function and reverses HIV-related immune activationPLoS Pathog201410el004543Search in Google Scholar
Trinh QM, Nguyen HL, Nguyen VN, Nguyen TV, Sintchenko V, Marais BJ. Tuberculosis and HIV co-infection—focus on the Asia-Pacific region. Int J Infect Dis. 2015; 32:170-8.10.1016/j.ijid.2014.11.02325809776TrinhQMNguyenHLNguyenVNNguyenTVSintchenkoVMaraisBJTuberculosis and HIV co-infection—focus on the Asia-Pacific regionInt J Infect Dis2015321708Open DOISearch in Google Scholar
Sudjaritruk T, Maleesatharn A, Prasitsuebsai W. TREAT Asia Pediatrie HIV Observational Database. Prevalence, characteristics, management, and outcome of pulmonary tuberculosis in HIV-infected children in the TREAT Asia pediatric HIV Observational Database (TApHOD). AIDS Patient Care STDS. 2013; 27:649-56.10.1089/apc.2013.0236SudjaritrukTMaleesatharnAPrasitsuebsaiWTREAT Asia Pediatrie HIV Observational Database. Prevalence, characteristics, management, and outcome of pulmonary tuberculosis in HIV-infected children in the TREAT Asia pediatric HIV Observational Database (TApHOD)AIDS Patient Care STDS20132764956Open DOISearch in Google Scholar
Han SH, Zhou J, Lee MP, Zhao H, TREAT Asia HIV Observational Database. Prognostic significance of the interval between the initiation of antiretroviral therapy and the initiation of anti-tuberculosis treatment in HIV/tuberculosis-coinfected patients: results from the TREAT Asia HIV Observational Database. HIV Med 2014; 15:77-85.23980589HanSHZhouJLeeMPZhaoHTREAT Asia HIV Observational Database. Prognostic significance of the interval between the initiation of antiretroviral therapy and the initiation of anti-tuberculosis treatment in HIV/tuberculosis-coinfected patients: results from the TREAT Asia HIV Observational DatabaseHIV Med201415778510.1111/hiv.12073Search in Google Scholar
Zhang F, Zhu H, Wu Y, Dou Z, Zhang Y, Kleinman N, et al. HIV, hepatitis B virus, and hepatitis C virus co-infection in patients in the China National Free Antiretroviral Treatment Program, 2010-12: a retrospective observational cohort study. Lancet Infect Dis. 2014; 14:1065-72.10.1016/S1473-3099(14)70946-625303841ZhangFZhuHWuYDouZZhangYKleinmanNet alHIV, hepatitis B virus, and hepatitis C virus co-infection in patients in the China National Free Antiretroviral Treatment Program, 2010-12: a retrospective observational cohort studyLancet Infect Dis201414106572Open DOISearch in Google Scholar
van Griensven J, Phirum L, Choun K, Thai S, De Weggheleire A, LynenL. Hepatitis B and C co-infection among HIV-infected adults while on antiretroviral treatment: long-term survival, CD4 cell count recovery and antiretroviral toxicity in Cambodia. PLoS One. 2014;9:e88552.2453310610.1371/journal.pone.0088552van GriensvenJPhirumLChounKThaiSDe WeggheleireALynenLHepatitis B and C co-infection among HIV-infected adults while on antiretroviral treatment: long-term survival, CD4 cell count recovery and antiretroviral toxicity in CambodiaPLoS One20149e88552392287024533106Search in Google Scholar
Law WP, Duncombe CJ, Mahanontharit A, Boyd MA, Ruxrungtham K, Lange JM, et al. Impact of viral hepatitis co-infection on response to antiretroviral therapy and HIV disease progression in the HIV-NAT cohort. AIDS. 2004; 18:1169-77.1516653210.1097/00002030-200405210-00010LawWPDuncombeCJMahanontharitABoydMARuxrungthamKLangeJMet alImpact of viral hepatitis co-infection on response to antiretroviral therapy and HIV disease progression in the HIV-NAT cohortAIDS20041811697715166532Search in Google Scholar
Zaw SK, Tun ST, Thida A, Aung TK, Maung W, Shwe M, et al. Prevalence of hepatitis C and B virus among patients infected with HIV: a cross-sectional analysis of a large HIV care programme in Myanmar Trop Doct. 2013; 43:113-5.ZawSKTunSTThidaAAungTKMaungWShweMet alPrevalence of hepatitis C and B virus among patients infected with HIVa cross-sectional analysis of a large HIV care programme in Myanmar Trop Doct201343113510.1177/004947551349341623800421Search in Google Scholar
Sereno L, Mesquita F, Kato M, Jacka D, Nguyen TT, Nguyen TN. The silent epidemic of viral hepatitis and HIV coinfection in Vietnam. J Int Assoc Physicians AIDS Care (Chic). 2012; 11:311-20.10.1177/154510971245393922828983SerenoLMesquitaFKatoMJackaDNguyenTTNguyenTNThe silent epidemic of viral hepatitis and HIV coinfection in VietnamJ Int Assoc Physicians AIDS Care (Chic)2012113112022828983Open DOISearch in Google Scholar
Jackson JB, Wei L, Liping F, Aramrattana A, Celentano DD, Walshe L, et al. Prevalence and seroincidence of hepatitis B and hepatitis C infection in high risk people who inject drugs in china and Thailand. Hepat Res Treat. 2014; 2014:296958.24860664JacksonJBWeiLLipingFAramrattanaACelentanoDDWalsheLet alPrevalence and seroincidence of hepatitis B and hepatitis C infection in high risk people who inject drugs in china and ThailandHepat Res Treat2014201429695810.1155/2014/296958398532424860664Search in Google Scholar
Tsuchiya N, Pathipvanich P, Rojanawiwat A, Wichukchinda N, Koga I, Koga M, et al. Chronic hepatitis B and C co-infection increased all-cause mortality in HAART-naive HIV patients in Northern Thailand. Epidemiol Infect. 2013; 141:1840-8.2311426210.1017/S0950268812002397TsuchiyaNPathipvanichPRojanawiwatAWichukchindaNKogaIKogaMet alChronic hepatitis B and C co-infection increased all-cause mortality in HAART-naive HIV patients in Northern ThailandEpidemiol Infect201314118408375736523114262Search in Google Scholar
Maek-A-Nantawat W, Avihingsanon A, Ohata PJ. Challenges in providing treatment and care for viral hepatitis among individuals co-infected with HIV in resource-limited settings. AIDS Res Treat. 2012; 2012: 948059.22536498Maek-A-NantawatWAvihingsanonAOhataPJChallenges in providing treatment and care for viral hepatitis among individuals co-infected with HIV in resource-limited settingsAIDS Res Treat2012201294805910.1155/2012/948059331819622536498Search in Google Scholar
Crane M, Avihingsanon A, Rajasuriar R, Velayudham P, IserD, Solomon A, et al. Lipopolysaccharide, immune activation, and liver abnormalities in HIV/hepatitis B virus (HBV)-coinfected individuals receiving HBV-active combination antiretroviral therapy. J Infect Dis. 2014;210:745-51.2458589810.1093/infdis/jiu119CraneMAvihingsanonARajasuriarRVelayudhamPIserDSolomonAet alLipopolysaccharide, immune activation, and liver abnormalities in HIV/hepatitis B virus (HBV)-coinfected individuals receiving HBV-active combination antiretroviral therapyJ Infect Dis20142107455124585898Search in Google Scholar
Andrade BB, Hullsiek KH, Boulware DR, Rupert A, INSIGHT Study Group. Biomarkers of inflammation and coagulation are associated with mortality and hepatitis flares in persons coinfected with HIV and hepatitis viruses. J Infect Dis. 2013 ; 207:1379-88.10.1093/infdis/jit033AndradeBBHullsiekKHBoulwareDRRupertAINSIGHT Study Group. Biomarkers of inflammation and coagulation are associated with mortality and hepatitis flares in persons coinfected with HIV and hepatitis virusesJ Infect Dis2013207137988361042123335804Open DOISearch in Google Scholar
Matthews GV, Avihingsanon A, Lewin SR, Amin J, Rerknimitr R, Petcharapirat P, et al. Arandomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naive individuals in Thailand. Hepatology. 2008; 48:1062-9.10.1002/hep.22462MatthewsGVAvihingsanonALewinSRAminJRerknimitrRPetcharapiratPet alArandomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naive individuals in ThailandHepatology2008481062918697216Open DOISearch in Google Scholar
Avihingsanon A, Lewin SR, Kerr S, Chang JJ, Piyawat K, Napissanant N, et al. Efficacy of tenofovir disoproxil fumarate/emtricitabine compared with emtricitabine alone in antiretroviral-naive HIV-HBV coinfection in Thailand. Antivir Ther. 2010; 15:917-22.10.3851/IMP164520834105AvihingsanonALewinSRKerrSChangJJPiyawatKNapissanantNet alEfficacy of tenofovir disoproxil fumarate/emtricitabine compared with emtricitabine alone in antiretroviral-naive HIV-HBV coinfection in ThailandAntivir Ther2010159172220834105Open DOISearch in Google Scholar
Avihingsanon A, Matthews GV, Lewin SR, Marks P, Sasadeusz J, Cooper DA, et al. Assessment of HBV flare in a randomized clinical trial in HIV/HBV coinfected subjects initiating HBV-active antiretroviral therapy in Thailand. AIDS Res Ther. 2012; 9:6.10.1186/1742-6405-9-6AvihingsanonAMatthewsGVLewinSRMarksPSasadeuszJCooperDAet alAssessment of HBV flare in a randomized clinical trial in HIV/HBV coinfected subjects initiating HBV-active antiretroviral therapy in ThailandAIDS Res Ther201296332437822405335Open DOISearch in Google Scholar
Avihingsanon A, Apornpong T, Ramautarsing RA, Ubolyam S, HIV-NAT 105 study team. Decline in serum 25 hydroxyvitamin D levels in HIV-HBV-coinfected patients after long-term antiretroviral therapy. Antivir Ther. 2014; 19:41-9.AvihingsanonAApornpongTRamautarsingRAUbolyamSHIV-NAT 105 study team. Decline in serum 25 hydroxyvitamin D levels in HIV-HBV-coinfected patients after long-term antiretroviral therapyAntivir Ther20141941910.3851/IMP267323970149Search in Google Scholar
Qi J, Zhang D, Fu X, Li C, Meng S, Dai M, et al. High risks of HIV transmission for men who have sex with men - a comparison of risk factors of HIV infection among MSM associated with recruitment channels in 15 cities of China. PLoS One. 2015; 10:e0121267.10.1371/journal.pone.012126725837667QiJZhangDFuXLiCMengSDaiMet alHigh risks of HIV transmission for men who have sex with men - a comparison of risk factors of HIV infection among MSM associated with recruitment channels in 15 cities of ChinaPLoS One201510e0121267438354025837667Open DOISearch in Google Scholar
Solomon MM, Mayer KH, Glidden D V, Liu AY, iPrEx Study Team. Syphilis predicts HIV incidence among men and transgender women who have sex with men in a pre-exposure prophylaxis trial. Clin Infect Dis. 2014;59:1020-6.10.1093/cid/ciu450SolomonMMMayerKHGliddenDVLiuAYiPrEx Study Team. Syphilis predicts HIV incidence among men and transgender women who have sex with men in a pre-exposure prophylaxis trialClin Infect Dis20145910206416698024928295Open DOISearch in Google Scholar
Holtz TH, Thienkrua W, McNicholl JM, Wimonsate W, Chaikummao S, Chonwattana W, et al. Prevalence of treponema pallidum seropositivity and herpes simplex virus type 2 infection in a cohort of men who have sex with men, Bangkok, Thailand, 2006-2010. Int J STD AIDS. 2012; 23:424-8.HoltzTHThienkruaWMcNichollJMWimonsateWChaikummaoSChonwattanaWet alPrevalence of treponema pallidum seropositivity and herpes simplex virus type 2 infection in a cohort of men who have sex with menBangkokThailand20062010Int J STD AIDS201223424810.1258/ijsa.2011.011256Search in Google Scholar
Morineau G, Bollen LJ, Syafitri RI, Nurjannah N, Mustikawati DE, Magnani R. HIV prevalence and risk behaviours among injecting drug users in six Indonesian cities implications for future HIV prevention programs. Harm Reduct J. 2012; 9:37.2294343810.1186/1477-7517-9-37MorineauGBollenLJSyafitriRINurjannahNMustikawatiDEMagnaniRHIV prevalence and risk behaviours among injecting drug users in six Indonesian cities implications for future HIV prevention programsHarm Reduct J2012937Search in Google Scholar
Huang S, Tang W, Zhu Z, Lu H, Tan X, Zhang B, et al. Higher prevalence of sexual transmitted diseases and correlates of genital warts among heterosexual males attending sexually transmitted infection clinics (MSCs) in Jiangmen, China: implication for the up-taking of STD related service. PLoS One. 2015; 10:e0121814.25811185HuangSTangWZhuZLuHTanXZhangBet alHigher prevalence of sexual transmitted diseases and correlates of genital warts among heterosexual males attending sexually transmitted infection clinics (MSCs) in JiangmenChinaimplication for the up-taking of STD related servicePLoS One201510e012181410.1371/journal.pone.0121814Search in Google Scholar
Phanuphak N, Pankam T, Pattanachaiwit S, Chamnan P, Pathipvanich P, Thongpaen S, et al. High prevalence of STI among Thai MSM and transgender women and its correlation with HIV RNA levels in ano-genital compartments prior to antiretroviral therapy: implication for treatment as prevention program. AIDS 2014; 20th International AIDS conference. July 20-25, Melbourne, Australia, 2014. TUPE062 (Poster abstract).PhanuphakNPankamTPattanachaiwitSChamnanPPathipvanichPThongpaenSet alHigh prevalence of STI among Thai MSM and transgender women and its correlation with HIV RNA levels in ano-genital compartments prior to antiretroviral therapy: implication for treatment as prevention program AIDS201420th International AIDS conferenceJuly2025Melbourne, Australia2014TUPE062 (Poster abstract)Search in Google Scholar
World Health Organization (WHO). Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection, 2013. [Cited 2015 April 24]. Available from: http://www.who.int/hiv/pub/guidelines/arv2013/download/en/World Health Organization (WHO). Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection2013[Cited 2015 April 24]. Available fromhttp://www.who.int/hiv/pub/guidelines/arv2013/download/en/Search in Google Scholar
Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services, 2014. [Cited 2015 May 2]. Available from: http://aidsinfo.nih.gov/contentfiles/lvguidelines/AdultandAdolescentGL.pdfPanel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescentsDepartment of Health and Human Services2014[Cited 2015 May 2]. Available fromhttp://aidsinfo.nih.gov/contentfiles/lvguidelines/AdultandAdolescentGL.pdfSearch in Google Scholar
Manosuthi W, Ongwandee S, Bhakeecheep S, Leechawengwongs, et al. Adults and Adolescents Committee of the Thai National HIV Guidelines Working Group. Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents 2014, Thailand. AIDS Res Ther. 2015; 12:12.ManosuthiWOngwandeeSBhakeecheepSLeechawengwongset alAdults and Adolescents Committee of the Thai National HIV Guidelines Working GroupGuidelines for antiretroviral therapy in HIV-1 infected adults and adolescents2014ThailandAIDS Res Ther2015121210.1186/s12981-015-0053-zSearch in Google Scholar
NIH News. Starting antiretroviral treatment early improves outcomes for HIV-infected individuals, 2015. [Cited 2015 July 31]. Available from: http://www.niaid.nih.gov/news/newsreleases/2015/Pages/START.aspxNIH News. Starting antiretroviral treatment early improves outcomes for HIV-infected individuals2015[Cited 2015 July 31]. Available fromhttp://www.niaid.nih.gov/news/newsreleases/2015/Pages/START.aspxSearch in Google Scholar
Kyaw NL, Thanachartwet V, Kiertiburanakul S, Desakorn V, Chamnanchanunt S, Chierakul W, et al. Baseline CD4 cell counts and outcomes among adult treatment naive HIV patients after taking fixed dose combination GPO-VIR-S and GPO-VIR-Z in Thailand. Southeast Asian J Trop Med Public Health. 2013; 44: 232-43.23691633KyawNLThanachartwetVKiertiburanakulSDesakornVChamnanchanuntSChierakulWet alBaseline CD4 cell counts and outcomes among adult treatment naive HIV patients after taking fixed dose combination GPO-VIR-S and GPO-VIR-Z in ThailandSoutheast Asian J Trop Med Public Health20134423243Search in Google Scholar
van Griensven J, Phan V, Thai S, Koole O, Lynen L. Simplified clinical prediction scores to target viral load testing in adults with suspected first line treatment failure in Phnom Penh, Cambodia. PLoS One. 2014; 9: e87879.10.1371/journal.pone.008787924504463van GriensvenJPhanVThaiSKooleOLynenLSimplified clinical prediction scores to target viral load testing in adults with suspected first line treatment failure in Phnom Penh, CambodiaPLoS One20149e87879Open DOISearch in Google Scholar
Chen J, Yu B, Wang Y, Tang M, Hu Y, Cai T, et al. Expansion of HIV care and treatment in Yunnan Province, China: treatment outcomes with scale up of combination antiretroviral therapy. AIDS Care. 2014; 26:633-41.ChenJYuBWangYTangMHuYCaiTet alExpansion of HIV care and treatment in Yunnan ProvinceChinatreatment outcomes with scale up of combination antiretroviral therapy. AIDS Care2014266334110.1080/09540121.2013.845281Search in Google Scholar
Nguyen DB, Do NT, Shiraishi RW, Le YN, Tran QH, Huu Nguyen H, et al. Outcomes of antiretroviral therapy in Vietnam: results from a national evaluation. PLoS One. 2013; 8:e55750.10.1371/journal.pone.005575023457477NguyenDBDoNTShiraishiRWLeYNTranQHHuu NguyenHet alOutcomes of antiretroviral therapy in Vietnam: results from a national evaluationPLoS One20138e55750Open DOISearch in Google Scholar
Gupta A, Nadkarni G Yang WT, Chandrasekhar A, Gupte N, Bisson GP, et al. Early mortality in adults initiating antiretroviral therapy (ART) in low- and middle-income countries (LMIC): a systematic review and meta-analysis. PLoS One. 2011; 6:e28691.2222019310.1371/journal.pone.0028691GuptaANadkarniGYangWTChandrasekharAGupteNBissonGPet alEarly mortality in adults initiating antiretroviral therapy (ART) in low- and middle-income countries (LMIC): a systematic review and meta-analysisPLoS One20116e28691Search in Google Scholar
DART Trial Team, Mugyenyi P, Walker AS, Hakim J, et al. Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial. Lancet. 2010 Jan9; 375:123-31.20004464DART Trial TeamMugyenyiPWalkerASHakimJet alRoutine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trialLancet2010Jan93751233110.1016/S0140-6736(09)62067-5Search in Google Scholar
Laurent C, Kouanfack C, Laborde-Balen G Aghokeng AF, ANRS 12110/ESTHER study group. Monitoring of HIV viral loads, CD4 cell counts, and clinical assessments versus clinical monitoring alone for antiretroviral therapy in rural district hospitals in Cameroon: a randomised non-inferiority trial. Lancet Infect Dis. 2011; 11:825-33.10.1016/S1473-3099(11)70168-2LaurentCKouanfackCLaborde-BalenGAghokengAFANRS 12110/ESTHER study group. Monitoring of HIV viral loads, CD4 cell counts, and clinical assessments versus clinical monitoring alone for antiretroviral therapy in rural district hospitals in Cameroon: a randomised non-inferiority trialLancet InfectDis20111182533Open DOISearch in Google Scholar
Bryant L, Smith N, Keiser P. A model for reduced HIV-1 viral load monitoring in resource-limited settings. J Int Assoc Provid AIDS Care. 2013; 12:67-71.BryantLSmithNKeiserPA model for reduced HIV-1 viral load monitoring in resource-limited settingsJ Int AssocProvidAIDS Care201312677110.1177/154510971244200722553318Search in Google Scholar
Liang J, Duan S, Ma YL, Wang JB, Su YZ, Zhang H, et al. Evaluation of PIMA Point-of-care CD4 Analyzer in Yunnan, China. Chin Med J (Engl). 2015; 128:890-5.2583660810.4103/0366-6999.154283LiangJDuanSMaYLWangJBSuYZZhangHet alEvaluation of PIMA Point-of-care CD4 Analyzer in Yunnan, ChinaChin Med J (Engl)20151288905483400425836608Search in Google Scholar
Thakar M, Mahajan B, Shaikh N, Bagwan S, Sane S, Kabra S, et al. Utility of the point of care CD4 analyzer. PIMA, to enumerate CD4 counts in the field settings in India. AIDS Res Ther 2012; 9:26.2299873810.1186/1742-6405-9-26ThakarMMahajanBShaikhNBagwanSSaneSKabraSet alUtility of the point of care CD4 analyzerPIMA, to enumerate CD4 counts in the field settings in IndiaAIDS Res Ther2012926350357822998738Search in Google Scholar
Sukapirom K, Onlamoon N, Thepthai C, Polsrila K, Tassaneetrithep B, Pattanapanyasat K. Performance evaluation of the Alere PIMA CD4 test for monitoring HIV-infected individuals in resource-constrained settings. J Acquir Immune Defic Syndr. 2011; 58:141-7.10.1097/QAI.0b013e31822866a221709568SukapiromKOnlamoonNThepthaiCPolsrilaKTassaneetrithepBPattanapanyasatKPerformance evaluation of the Alere PIMA CD4 test for monitoring HIV-infected individuals in resource-constrained settingsJ Acquir Immune Defic Syndr201158141721709568Open DOISearch in Google Scholar
Wade D, Daneau G, Aboud S, Vercauteren GH. WHO multicenter evaluation of FACSCount CD4 and Pima CD4 T-cell count systems: instrument performance and misclassification of HIV-infected patients. J Acquir Immune Defic Syndr. 2014; 66:e98-107.2485330410.1097/QAI.0000000000000214WadeDDaneauGAboudSVercauterenGHWHO multicenter evaluation of FACSCount CD4 and Pima CD4 T-cell count systems: instrument performance and misclassification of HIV-infected patientsJ Acquir Immune Defic Syndr201466e98107414964524853304Search in Google Scholar
Ritchie AV, Ushiro-Lumb I, Edemaga D, Joshi HA, De Ruiter A, Szumilin E, et al. SAMBA HIV semiquantitative test, a new point-of-care viral-load-monitoring assay for resource-limited settings. J Clin Mcrobiol. 2014; 52:3377-83.10.1128/JCM.00593-14RitchieAVUshiro-LumbIEdemagaDJoshiHADe RuiterASzumilinEet alSAMBA HIV semiquantitative test, a new point-of-care viral-load-monitoring assay for resource-limited settingsJ Clin Mcrobiol201452337783431316525031444Open DOISearch in Google Scholar
Scott L, Gous N, Cannona S, Stevens W.Laboratory evaluation of the Liat HIV Quant (IQuum) whole blood and plasma HIV-1 viral load assays for point-of-care testing in South Africa. J Clin Microbiol. 2015; 53: 1616-21.2574077710.1128/JCM.03325-14ScottLGousNCannonaSStevensWLaboratory evaluation of the Liat HIV Quant (IQuum) whole blood and plasma HIV-1 viral load assays for point-of-care testing in South AfricaJ Clin Microbiol201553161621440074725740777Search in Google Scholar
Shafiee H, Wang S, Inci F, Toy M, Henrich TJ, Kuritzkes DR, Demirci U. Emerging technologies for point-of-care management of HIV infection. Annu Rev Med 2015; 66:387-405.2542359710.1146/annurev-med-092112-143017ShafieeHWangSInciFToyMHenrichTJKuritzkesDRDemirciUEmerging technologies for point-of-care management of HIV infectionAnnu Rev Med20156638740525423597Search in Google Scholar
Ahn JY, Boettiger D, Law M, Kumarasamy N, Yunihastuti E, Chaiwarith R, et al. Effects of CD4 monitoring frequency on clinical endpoints in clinically stable HIV-infected patients with viral suppression. J Acquir Immune Defic Syndr. 2015; 69:e85-9210.1097/QAI.0000000000000634AhnJYBoettigerDLawMKumarasamyNYunihastutiEChaiwarithRet alEffects of CD4 monitoring frequency on clinical endpoints in clinically stable HIV-infected patients with viral suppressionJ Acquir Immune Defic Syndr201569e8592450669925850606Open DOISearch in Google Scholar
HillA. Optimizing HIV treatment. Curr Opin HIV AIDS. 2013; 8:34-40.HillAOptimizingHIVtreatmentCurrOpinHIVAIDS20138344010.1097/COH.0b013e32835b7f2823143139Search in Google Scholar
Avihingsanon A, Manosuthi W, Kantipong P, Chuchotaworn C, Moolphate S, Sakornjun W, et al. Pharmacokinetics and 48-week efficacy of nevirapine: 400 mg versus 600 mg per day in HIV-tuberculosis coinfection receiving rifampicin. Antivir Ther. 2008; 13: 529-36.AvihingsanonAManosuthiWKantipongPChuchotawornCMoolphateSSakornjunWet alPharmacokinetics and 48-week efficacy of nevirapine: 400 mg versus 600 mg per day in HIV-tuberculosis coinfection receiving rifampicin Antivir Ther2008135293610.1177/135965350801300414Search in Google Scholar
Avihingsanon A, van der Lugt J, Kerr S J, Gorowara M, Chanmano S, Ohata P, et al. A low dose of ritonavir-boosted atazanavir provides adequate pharmacokinetic parameters in HIV-1-infected Thai adults. Clin Pharmacol Ther. 2009; 85:402-8.10.1038/clpt.2008.24419118378AvihingsanonAvan der LugtJKerrS JGorowaraMChanmanoSOhataPet alA low dose of ritonavir-boosted atazanavir provides adequate pharmacokinetic parameters in HIV-1-infected Thai adultsClin Pharmacol Ther2009854028Open DOISearch in Google Scholar
Klinklom A, Puthanakit T, Gorowara M, Phasomsap C, Kerr S, Sriheara C, et al. Low dose lopinavir/ritonavir tablet achieves adequate pharmacokinetic parameters in HIV-infected Thai adolescents. Antivir Ther. 2012; 17:283-9.22293065KlinklomAPuthanakitTGorowaraMPhasomsapCKerrSSrihearaCet alLow dose lopinavir/ritonavir tablet achieves adequate pharmacokinetic parameters in HIV-infected Thai adolescentsAntivir Ther201217283910.3851/IMP1958Search in Google Scholar
ENCORE1 Study Group, Puls R, Amin J, Losso M, Phanuphak P, Nwizu C, et al. Efficacy of 400 mg efavirenz versus standard 600 mg dose in HIV-infected, antiretroviral-naive adults (ENCORE1): randomised, double-blind, placebo-controlled, non-inferiority trial. Lancet. 2014; 383:1474-82.ENCORE1 Study GroupPulsRAminJLossoMPhanuphakPNwizuCet alEfficacy of 400 mg efavirenz versus standard 600 mg dose in HIV-infected, antiretroviral-naive adults (ENCORE1): randomised, double-blind, placebo-controlled, non-inferiority trialLancet201438314748210.1016/S0140-6736(13)62187-XSearch in Google Scholar
Ananworanich J, Gorowara M, Avihingsanon A, Kerr SJ, HIV-NAT 127 Study Team. Pharmacokinetics of and short-term virologie response to low-dose 400-milligram once-daily raltegravir maintenance therapy. Antimicrob Agents Chemother. 2012; 56:1892-8.10.1128/AAC.05694-11AnanworanichJGorowaraMAvihingsanonAKerrSJHIV-NAT 127 Study Team. Pharmacokinetics of and short-term virologie response to low-dose 400-milligram once-daily raltegravir maintenance therapyAntimicrob Agents Chemjournal20125618928331838322252825Open DOISearch in Google Scholar
Puthanakit T, Suntarattiwong P, Sangkla P, Kosalaraksa P, Ngampiyaskul C, Srisamang P, et al. A randomized study comparing low dose versus standard dose lopinavir/ritonavir among HIV-infected children with virological suppression. The 7th International AIDS Society Conference on HIV pathogenesis, treatment and prevention. June 30-July 3, 2013, Kuala Lumpur, Malaysia. Abstract MOABOlOl.PuthanakitTSuntarattiwongPSangklaPKosalaraksaPNgampiyaskulCSrisamangPet alA randomized study comparing low dose versus standard dose lopinavir/ritonavir among HIV-infected children with virological suppressionThe 7th International AIDS Society Conference on HIV pathogenesis, treatment and preventionJune30July32013KualaLumpur, MalaysiaAbstract MOABOlOlSearch in Google Scholar
Low dose atazanavir/r versus standard dose atazanavir/r (LASA), 2015. [Cited 2015 April 15], Available from: https://clinicaltrials.gov/ct2/show/NCT01159223Low dose atazanavir/r versus standard dose atazanavir/r (LASA)2015[Cited 2015 April 15], Available fromhttps://clinicaltrials.gov/ct2/show/NCT01159223Search in Google Scholar
Phongsamart W, Hansudewechakul R, Bunupuradah T, Klinbuayaem V, Teeraananchai S, Prasithsirikul W, et al. Long-term outcomes of HIV-infected children in Thailand: the Thailand pediatric HIV observational database. IntJ Infect Dis. 2014; 22:19-24.10.1016/j.ijid.2013.12.011PhongsamartWHansudewechakulRBunupuradahTKlinbuayaemVTeeraananchaiSPrasithsirikulWet alLong-term outcomes of HIV-infected children in Thailand: the Thailand pediatric HIV observational databaseIntJ Infect Dis201422192424576843Open DOISearch in Google Scholar
Koller M, Patel K, Chi BH, Wools-Kaloustian K, IeDEA, NISDI, PHACS and IMPAACT 219C studies. Immunodeficiency in children starting antiretroviral therapy in low-, middle-, and high-income countries. J Acquir Immune Defic Syndr. 2015; 68:62-72.KollerMPatelKChiBHWools-KaloustianKIeDEA, NISDI, PHACS and IMPAACT 219C studiesImmunodeficiency in children starting antiretroviral therapy in low-, middle-, and high-income countries. J Acquir Immune Defic Syndr201568627210.1097/QAI.0000000000000380435130225501345Search in Google Scholar
Pham H, Ishizaki A, Nguyen L, Phan C, Phung T, Takemoto K, et al. Two-year outcome of first-line antiretroviral therapy among HIV-1 vertically infected children in Hanoi, Vietnam. Int J STD AIDS. 2015:26: 821-30.10.1177/095646241455632825332224PhamHIshizakiANguyenLPhanCPhungTTakemotoKet alTwo-year outcome of first-line antiretroviral therapy among HIV-1 vertically infected children in Hanoi, VietnamInt J STD AIDS2015268213025332224Open DOISearch in Google Scholar
N PG Kumar AM, Chinnakali P, Sahu S, M S, As V, et al. High loss to follow up among children on pre-art care under national AIDS program in Madurai, South India. J Acquir Immune Defic Syndr. 2015 Apr 8. [Epub ahead of print]NPGKumarAMChinnakaliPSahuSMSAsVet alHigh loss to follow up among children on pre-art care under national AID S program in Madurai, South IndiaJ Acquir Immune Defic Syndr2015Apr8[Epub ahead of print]Search in Google Scholar
TREAT Asia Pediatrie HIV Observational Database (TApHOD); International Epidemiologie Databases to Evaluate AIDS (IeDEA) Southern Africa Paediatric Group. A biregional survey and review of first-line treatment failure and second-line paediatric antiretroviral access and use in Asia and southern Africa. J Int AIDS Soc. 2011; 14:7.TREAT Asia Pediatrie HIV Observational Database (TApHOD); International Epidemiologie Databases to Evaluate AIDS (IeDEA) Southern Africa Paediatric GroupA biregional survey and review of first-line treatment failure and second-line paediatric antiretroviral access and use in Asia and southern Africa. J Int AIDS Soc201114710.1186/1758-2652-14-7305807521306608Search in Google Scholar
UNAIDS. Report: HIV in Asia-Pacific, 2013. [Cited 2015 July 31]. Available from: http://www.unaids.org/sites/default/files/media_asset/2013HIV-Asia-Pacific_en_0.pdfUNAIDS. Report: HIV in Asia-Pacific2013[Cited 2015 July 31]. Available fromhttp://www.unaids.org/sites/default/files/media_asset/2013HIV-Asia-Pacific_en_0.pdfSearch in Google Scholar
Han N, Wright ST, O’Connor CC, Hoy J, Ponnampalavanar S, Grotowski M, et al. Australian HIV Observational Database (AHOD); TREAT Asia HIV Observational Database (TAHOD). HIV and aging: insights from the Asia Pacific HIV Observational Database (APHOD). HIV Med 2015; 16:152-60.HanNWrightSTO’ConnorCCHoyJPonnampalavanarSGrotowskiMet alAustralian HIV Observational Database (AHOD); TREAT Asia HIV Observational Database (TAHOD)HIV and aging: insights from the Asia Pacific HIV Observational Database (APHOD). HIVMed2015161526010.1111/hiv.12188488477025407085Search in Google Scholar
Xie T, Wu N. Epidemiological and mortality analysis of older adults with HIV in eastern China. Clin Interv Aging. 2013; 8:1519-25.24277983XieTWuNEpidemiological and mortality analysis of older adults with HIV in eastern ChinaClin Interv Aging2013815192510.2147/CIA.S53657Search in Google Scholar
LiuH, LinX, Xu Y, Chen S, Shi J, Morisky D. Emerging HIV epidemic among older adults in Nanning, China. AIDS Patient Care STDS. 2012; 26:565-7.10.1089/apc.2012.022722984779LiuHLinXXuYChenSShiJMoriskyDEmerging HIV epidemic among older adults in Nanning, ChinaAIDS Patient Care STDS2012265657Open DOISearch in Google Scholar
Narayan KM, Miotti PG, Anand NP, Kline LM, Harmston C, Gulakowski R 3rd, Vermund SH. HIV and noncommunicable disease comorbidities in the era of antiretroviral therapy: a vital agenda for research in low- and middle-income country settings. J Acquir Immune Defic Syndr. 2014; 67 Suppl l:S2-7.10.1097/QAI.000000000000026725117958NarayanKMMiottiPGAnandNPKlineLMHarmstonCGulakowskiRVermundSHHIV and noncommunicable disease comorbidities in the era of antiretroviral therapy: a vital agenda for research in low- and middle-income country settingsJ Acquir Immune Defic Syndr201467s27Open DOISearch in Google Scholar
Boettiger DC, Nguyen VK, Durier N, Bui HV, Heng Sim BL, Azwa I, et al. Efficacy of second-line antiretroviral therapy among people living with HIV/ AIDS in Asia: results from the TREAT Asia HIV observational database. J Acquir Immune Defic Syndr. 2015;68:186-95.10.1097/QAI.000000000000041125590271BoettigerDCNguyenVKDurierNBuiHVHeng SimBLAzwaIet alEfficacy of second-line antiretroviral therapy among people living with HIV/ AIDS in Asia: results from the TREAT Asia HIV observational databaseJ Acquir Immune Defic Syndr20156818695Open DOISearch in Google Scholar
Kiertiburanakul S, Chaiwarith R, Sirivichayakul S, Ditangco R, for the TREAT Asia Studies to Evaluate Resistance Surveillance and Monitoring Studies. Comparisons of primary HIV-1 drug resistance between recent and chronic HIV-1 infection within a sub-regional cohort of Asian patients. PLoS One. 2013; 8:e62057.10.1371/journal.pone.006205723826076KiertiburanakulSChaiwarithRSirivichayakulSDitangcoRfor the TREAT Asia Studies to Evaluate Resistance Surveillance and Monitoring Studies. Comparisons of primary HIV-1 drug resistance between recent and chronic HIV-1 infection within a sub-regional cohort of Asian patientsPLoS One20138e62057Open DOISearch in Google Scholar
Puthanakit T, Saphonn V, Ananworanich J, Kosalaraksa P, PREDICT Study Group. Early versus deferred antiretroviral therapy for children older than 1 year infected with HIV (PREDICT): a multicentre, randomised, open-label trial. Lancet Infect Dis. 2012; 12:933-41.10.1016/S1473-3099(12)70242-6PuthanakitTSaphonnVAnanworanichJKosalaraksaPPREDICT Study Group. Early versus deferred antiretroviral therapy for children older than 1 year infected with HIV (PREDICT): a multicentre, randomised, open-label trialLancet Infect Dis20121293341Open DOISearch in Google Scholar
Bunupuradah T, Chetchotisakd P, Ananworanich J, Munsakul W, HIV STAR Study Group. A randomized comparison of second-line lopinavir/ritonavir monotherapy versus tenofovir/lamivudine/lopinavir/ ritonavir in patients failing NNRTI regimens: the HIV STAR study. Antivir Ther 2012; 17:1351-61.10.3851/IMP2443BunupuradahTChetchotisakdPAnanworanichJMunsakulWHIV STAR Study Group. A randomized comparison of second-line lopinavir/ritonavir monjournalapy versus tenofovir/lamivudine/lopinavir/ ritonavir in patients failing NNRTI regimens: the HIV STAR studyAntivir Ther201217135161Open DOISearch in Google Scholar
Ananworanich J, Schuetz A, Vandergeeten C, Sereti I, de Souza M, Rerknimitr R et al. Impact of multi-targeted antiretroviral treatment on gut T cell depletion and HIV reservoir seeding during acute HIV infection. PLoS One. 2012; 7:e33948.10.1371/journal.pone.0033948AnanworanichJSchuetzAVandergeetenCSeretiIde SouzaMRerknimitrRet alImpact of multi-targeted antiretroviral treatment on gut T cell depletion and HIV reservoir seeding during acute HIV infectionPLoS One20127e33948Open DOISearch in Google Scholar
Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011; 365:493-505.10.1056/NEJMoa1105243CohenMSChenYQMcCauleyMGambleTHosseinipourMCKumarasamyNet alPrevention of HIV-1 infection with early antiretroviral therapyNEnglJMed2011365493505Open DOISearch in Google Scholar
SECOND-LINE Study Group, Boyd MA, Kumarasamy N, Moore CL, Nwizu C, et al. Ritonavir-boosted lopinavir plus nucleoside or nucleotide reverse transcriptase inhibitors versus ritonavir-boosted lopinavir plus raltegravir for treatment of HIV-1 infection in adults with virological failure of a standard first-line ART regimen (SECOND-LINE) : a randomised, open-label, non-inferiority study. Lancet. 2013; 381: 2091-9.23769235SECOND-LINE Study GroupBoydMAKumarasamyNMooreCLNwizuCet alRitonavir-boosted lopinavir plus nucleoside or nucleotide reverse transcriptase inhibitors versus ritonavir-boosted lopinavir plus raltegravir for treatment of HIV-1 infection in adults with virological failure of a standard first-line ART regimen (SECOND-LINE) : a randomised, open-label, non-inferiority studyLancet20133812091910.1016/S0140-6736(13)61164-2Search in Google Scholar
UNAIDS News. Asia and the Pacific countries commit to ending AIDS by 2030, 2015. [Cited 2015 May 2], Available from: http://unaids-ap.org/2015/01/30/asia-and-the-pacific-countries-commit-to-ending-aids-by-2030UNAIDS News. Asia and the Pacific countries commit to ending AIDS by 20302015[Cited 2015 May 2], Available fromhttp://unaids-ap.org/2015/01/30/asia-and-the-pacific-countries-commit-to-ending-aids-by-2030Search in Google Scholar
Grimsrud A, Balkan S, Casas EC, Lujan J, Van Cutsem G Poulet E, et al. Outcomes of antiretroviral therapy over a 10-year period of expansion: a multicohort analysis of African and Asian HIV programs. J Acquir Immune Defic Syndr. 2014; 67:e55-66.10.1097/QAI.0000000000000268GrimsrudABalkanSCasasECLujanJVan CutsemGPouletEet alOutcomes of antiretroviral therapy over a 10-year period of expansion: a multicohort analysis of African and Asian HIV programsJ Acquir Immune Defic Syndr201467e556624977472Open DOISearch in Google Scholar
Phanuphak P, Lo YR. Implementing early diagnosis and treatment: programmatic considerations. Curr Opin HIV AIDS. 2015; 10:69-75.PhanuphakPLoYRImplementing early diagnosis and treatment: programmatic considerations. Curr OpinHIVAIDS201510697510.1097/COH.000000000000012625389803Search in Google Scholar
Casseri MM, Holtz TH, Wolfe MI, Hahn M, Prybylski D. ‘Getting to zero’ in Asia and the Pacific through more strategic use of antiretrovirals for HIV prevention. Sex Health. 2014; 11:107-18.24942266CasseriMMHoltzTHWolfeMIHahnMPrybylskiD‘Getting to zero’ in Asia and the Pacific through more strategic use of antiretrovirals for HIV preventionSex Health2014111071810.1071/SH1311624942266Search in Google Scholar
